The expression of particular glucose transporters and insulin resistance indicators in the risk groups of type 2 diabetes - A two-year follow-up

Endokrynologia Polska

Volumn 63, Issue 3, 2012, Pages 212-219

  Bernat Karpińska, Małgorzata ^a   Pia̧tkiewicz, Paweł ^a   Czech, Anna ^a   Wierzbicki, Piotr ^b  

^a Brodnowski Hospital Warsaw   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Glucose transport; Glucose transporters (GLUT); Insulin resistance; Lymphocytes; Positive family history; Pre diabetes; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF CARBOHYDRATE METABOLISM; FAMILY HISTORY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LOW CALORY DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PERIPHERAL LYMPHOCYTE; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PEDIGREE; PREDIABETIC STATE; RISK FACTORS;

EID: 84864573179     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. World Health Organization (WHO). Fact Sheet No 312 Nov 2009. http://www.who.int/mediacentre/factsheets/fs312/en/ Accessed on Sept. 30, 2010
2. Wild S, Roglic G, Green A et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053. (Pubitemid 38579764)
3. Czech A, Tatoń J. Epidemics of diabetes mellitus and the burden of the social-financial costs - why in Poland the efficient programme of diabetes type 2 prevention is not practically implemented - "inertia preventiva"? Med Metabol 2010; 14: 43-48.
4. http://www.cdc.gov/diabetes/pubs/general07.htm
5. American Diabetes Association: Standards of Medical care in Diabetes - 2010. 33: S11-S61.
6. Nathan DM, Davidson MB, DeFronzo A et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-758.
7. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011; 378: 169-181.
8. R. Valdez. Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool. J Diabetes Sci Technol 2009; 3: 722-776.
9. Shaw JT, Purdie DM, Neil HA, Levy JC, Turner RC. The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with type II diabetes mellitus. Diabetologia 1999; 42: 24-27. (Pubitemid 29039732)
10. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987; 30: 763-768. (Pubitemid 17163001)
11. Warram JH, Martin BC, Krolewski AS, Soeledner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-915.
12. Zalecenia kliniczne dotycza̧ce postêpowania u chorych na cukrzycȩ 2011. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabet Prakt 2011; 12 (Suppl. A).
13. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe. Lancet 1999; 354: 617-621.
14. Hu FB, Stampfer MJ, Haffner SM et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2000; 25: 1129-1134.
15. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000; 23: 278-282.
16. Novoa FJ, Boronat M, Saavedra P et al. Differences in cardiovascular risk factors, insulin resistance and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: The Tedde Study. Diabetes Care 2007; 30: 753-759.
17. Amini M, Horri N, Zare M, Haghighi S, Hosseini SM. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: A study in first-degree relatives of type 2 diabetic patients. Ann Nutr Metab 2010; 56: 267-272.
18. Pia̧tkiewicz P, Kłosowska D, Czech A, Wierzbicki P, Nowaczyk M, Górski A, Tatoń J. Investigations of Glucotransporter 4 (GLUT4) expression in lymphocytes of healthy subjects and type 2 diabetic patients. Immunology 2004; 50: 203-206.
19. Szablewski L, Sobczyk-Kopcioł A, Oleszczak B, Nowak Ł, Grytner-Ziȩcina B. GLUT 4 is expressed in circulating lymphocytes of diabetic patients. A method to detect early prediabetic stages? Diabetologia Croat 2007; 36: 69-76. (Pubitemid 351631484)
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
21. Kaliman P, Viñals F, Testar X, Palacin M, Zorzano A. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem J 1995; 312: 471-477. (Pubitemid 26002213)
22. Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in policystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol 1993; 264 (2 Pt 1): E197-E202. (Pubitemid 23077359)
23. Bernat-Karpińska M, Czech A, Pia̧tkiewicz P, Wierzbicki P, Górski A. Cellular glucose transport disturbances as a marker of the prediabetic state - pathogenetic and clinical significance of the assessment of GLUT4 expression. Endokrynol Pol 2010; 61: 269-274.
24. Korgun ET, Demir R, Sedlmayr P et al. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 2002; 28: 152-159. (Pubitemid 34743749)
25. Szablewski L, Sobczyk-Kopcio? A, Oleszczak B, Mrozikiewicz-Rakowska B, Karnafel W, Grytner-Ziȩcina B. Expression of glucose transporters in peripheral blood cells in patients with type 2 diabetes mellitus depending on the mode of therapy. Exptl Clin Diab 2007; 7: 204-212. (Pubitemid 350219432)
26. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004; 53: 294-305. (Pubitemid 38174543)
27. Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W et al. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signalling in overweight nondiabetic and type 2 diabetic patients. Metabolism 2004; 53: 353-358.
28. Dela F, Ploug T, Handberg A, Peterson LN, Larsen JJ, Mikines KJ. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM (non-insulin-dependent diabetes mellitus). Diabetes 1994; 43: 747-753.
29. Hughes VA, Fiatarone MA, Fielding RA et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 1993; 264: E855-E862. (Pubitemid 23198558)
30. Kim HJ, Lee JS, Kim CK. Effects of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance. Eur J Appl Physiol 2004; 93: 353-335.
31. Graham TE, Yang Q, Blüher M., Hammarstedt A, Ciaraldi TP et al. Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects. N Engl J Med 2006; 354: 2552-2563. (Pubitemid 43882351)
32. Kipmen-Korgun D, Bilmen-Sarikcioglu S, Altunbas H, Demir R, Korgun ET. Type-2 diabetes down-regulates glucose transport proteins and genes of the human blood leukocytes. Scand J Clin Lab Invest 2009; 69: 350-358.
33. Karlsson HK, Ahlsén M, Zierath JR, Wallberg-Henriksson H, Koistinen HA. Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients. Diabetes 2006; 55: 1283-1288. (Pubitemid 44195366)
34. Torjesen PA, Birkeland KI, Anderssen SA et al. Lifestyle changes may reverse development of the insulin resistance syndrome: The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 1997; 20: 26-31.